{
    "id": "b9730e03baee7efc0359d08fae9cb2668772705eb774ea6ec93d732a4477fbb9",
    "metadata": "Cancer immunotherapy | Types of monoclonal antibodies | Cancer immunotherapy:Monoclonal antibodies",
    "metadata_info": "Concatenation of page title, section title and table caption.",
    "header": [
        "Antibody",
        "Brand_name",
        "Approval_date",
        "Type_",
        "Target",
        "Approved_treatments"
    ],
    "cell": [
        [
            "Alemtuzumab",
            "Campath",
            "2001",
            "humanized",
            "CD52",
            "Chronic lymphocytic leukemia"
        ],
        [
            "Bevacizumab",
            "Avastin",
            "2004",
            "humanized",
            "vascular endothelial growth factor",
            "colorectal cancer"
        ],
        [
            "Brentuximab vedotin",
            "Adcetris",
            "2011",
            "chimeric",
            "CD30",
            "Hodgkin lymphoma , Anaplastic large-cell lymphoma"
        ],
        [
            "Cetuximab",
            "Erbitux",
            "2004",
            "chimeric",
            "epidermal growth factor receptor",
            "colorectal cancer"
        ],
        [
            "Gemtuzumab ozogamicin",
            "Mylotarg",
            "2000",
            "humanized",
            "CD33",
            "acute myelogenous leukemia (with calicheamicin )"
        ],
        [
            "Panitumumab",
            "Vectibix",
            "2006",
            "human",
            "epidermal growth factor receptor",
            "colorectal cancer"
        ],
        [
            "Rituximab",
            "Rituxan, Mabthera",
            "1997",
            "chimeric",
            "CD20",
            "non-Hodgkin lymphoma"
        ]
    ],
    "source": "Open-WikiTable"
}